Bruker Announces Acquisition of High-Speed, 3D Super-Resolution Fluorescence Microscopy Company Vutara
28 July 2014 - 9:00PM
Business Wire
Bruker (NASDAQ:BRKR) today announced that it has acquired Vutara
Incorporated, a technology leader in high-speed, three-dimensional
(3D), super-resolution fluorescence microscopy for life science
applications. Transaction details were not disclosed. Vutara’s
estimated revenue for the full year 2014 is expected to be
approximately $2 million.
Bruker's Vutara 350 video-rate
super-resolution fluorescence microscope (above) unlocks the
potential of live-cell super-resolution imaging. The system was
designed to reflect real biologists' experimental needs, including
workflows and protocols that enable new users to become
self-sufficient in super-resolution microscopy in one day.(Photo:
Business Wire)
The acquisition further strengthens Bruker’s biological
microscopy business by adding super-resolution and single-molecule
localization (SML) microscopy products to Bruker’s existing
portfolio of multi-photon and fast, multi-point scanning confocal
fluorescence microscopes, as well as of high-performance atomic
force microscopes. Super-resolution microscopes can break the
optical diffraction limit by an order of magnitude, opening up a
myriad of research opportunities in single-molecule, cellular and
neurobiology processes.
“Super-resolution microscopy is emerging as a critical
requirement for our customers, and being able to integrate Vutara’s
best-in-class, high-speed, 3D super-resolution systems with our
line of multi-photon and multi-point scanning optical microscopy
technologies will provide a significant benefit to the research
community,” said Mark R. Munch, Ph.D., President of the Bruker MAT
Group. “Achieving video-rate time resolution, higher spatial
resolution, all with improved ease-of-use, is generating
considerable excitement in this rapidly growing area, and this is
exactly what Vutara brings to Bruker’s customers with its
proprietary technology.”
“Bruker’s prominence in life science research will further
accelerate the adoption of our performance-leading super-resolution
microscopes,” added Stan Kanarowski, CEO of Vutara Inc. “Moreover,
the combination of the Vutara and Bruker optical engineering and
microscopy application experts is expected to lead to the
development of a steady stream of additional innovative,
high-impact products for cell and neurobiology research.”
“We have seen firsthand the benefits that Bruker’s global
distribution and service capabilities can add to our advanced
multi-photon portfolio,” explained Mike Szulczewski, Vice President
and General Manager of the Bruker Fluorescence Microscopy business
unit. “I am pleased to have Vutara’s fast, 3D super-resolution and
SML technologies now added to our business, as this immediately
broadens our high-performance product offerings. It also allows us
to further develop our solutions for the next level of
functionality and versatility, with unique combinations of
resolution, speed, depth and ease of use on samples ranging from
live cells to living brains.”
About Vutara, Inc.
Vutara’s patented Biplane Imaging™ technology, along with other
key intellectual property, enables high-speed, 3D super-resolution
imaging for cutting-edge applications, such as multi-color
live-cell imaging. Vutara has rapidly grown and developed new
technology in SML super-resolution microscopy. Additionally, by
partnering with top researchers in the development of
super-resolution sample preparation protocols, and then seamlessly
integrating them into best-practice software workflows, Vutara has
created differentiated instruments that let novices quickly be
productive in super-resolution imaging. Founded in 2009 and located
in Salt Lake City, Utah, Vutara was started as a spinout from the
University of Utah (UU), as a collaboration between UU’s TVC and
Utah-based investors, including Kickstart Seed Fund, Signal Peak
Ventures and Park City Angels. For more information, please visit
www.vutara.com.
About Bruker Corporation
Bruker Corporation is a leading provider of high-performance,
scientific instruments and solutions for molecular, cellular and
materials research, as well as diagnostics, industrial, clinical
research and applied analysis. For more information, please visit
www.bruker.com.
Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20140728005197/en/
Media Contact:Bruker Nano Surfaces DivisionStephen
Hopkins, +1 520-741-1044 x1022Marketing
Communicationssteve.hopkins@bruker-nano.comorInvestor
Contact:Bruker CorporationJoshua Young, +1 978-663-3660
x1479Vice President, Investor RelationsJoshua.young@bruker.com
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Sep 2024 to Oct 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Oct 2023 to Oct 2024